BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37083697)

  • 21. 68 Ga-FAPI and 18 F-FDG PET/CT in Intravenous Leiomyomatosis.
    Li Z; Su D; Chen Y
    Clin Nucl Med; 2023 Nov; 48(11):994-996. PubMed ID: 37796170
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Accurate preoperative staging with [
    Chen S; Chen Z; Zou G; Zheng S; Zheng K; Zhang J; Huang C; Yao S; Miao W
    Eur Radiol; 2022 Sep; 32(9):6070-6079. PubMed ID: 35352157
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Positron emission tomography and computed tomography with [
    Pang Y; Zhao L; Shang Q; Meng T; Zhao L; Feng L; Wang S; Guo P; Wu X; Lin Q; Wu H; Huang W; Sun L; Chen H
    Eur J Nucl Med Mol Imaging; 2022 Mar; 49(4):1322-1337. PubMed ID: 34651226
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Usefulness of [
    Chen H; Zhao L; Ruan D; Pang Y; Hao B; Dai Y; Wu X; Guo W; Fan C; Wu J; Huang W; Lin Q; Sun L; Wu H
    Eur J Nucl Med Mol Imaging; 2021 Jan; 48(1):73-86. PubMed ID: 32588089
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparisons of Quantitative Parameters of Ga-68-Labelled Fibroblast Activating Protein Inhibitor (FAPI) PET/CT and [
    Siripongsatian D; Promteangtrong C; Kunawudhi A; Kiatkittikul P; Boonkawin N; Chinnanthachai C; Jantarato A; Chotipanich C
    Mol Imaging Biol; 2022 Oct; 24(5):818-829. PubMed ID: 35486293
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The potential utility of [
    Lan L; Liu H; Wang Y; Deng J; Peng D; Feng Y; Wang L; Chen Y; Qiu L
    Eur J Nucl Med Mol Imaging; 2022 Feb; 49(3):963-979. PubMed ID: 34410435
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of 68 Ga-FAPI PET/CT in Screening Malignancy of Familial Adenomatous Polyposis.
    Erol Fenercioğlu Ö; Yarikkaya E; Beyhan E; Çermik TF; Ergül N
    Clin Nucl Med; 2023 Mar; 48(3):e141-e142. PubMed ID: 36240760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of 18 F-FDG PET/CT and 68 Ga-FAPI-04 PET/CT in patients with non-small cell lung cancer.
    Can C; Kepenek F; Kömek H; Gündoğan C; Kaplan İ; Taşdemir B; Güzel Y; Agüloğlu N; Karaoğlan H
    Nucl Med Commun; 2022 Oct; 43(10):1084-1091. PubMed ID: 35972340
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Superiority of [
    Fu L; Huang S; Wu H; Dong Y; Xie F; Wu R; Zhou K; Tang G; Zhou W
    Eur Radiol; 2022 Sep; 32(9):6281-6290. PubMed ID: 35380229
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of PET imaging of activated fibroblasts and
    Shi X; Xing H; Yang X; Li F; Yao S; Congwei J; Zhao H; Hacker M; Huo L; Li X
    Eur J Nucl Med Mol Imaging; 2021 May; 48(5):1593-1603. PubMed ID: 33097975
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 68 Ga-FAPI Versus 18 F-FDG PET/CT in the Evaluation of Epithelioid Hemangioendothelioma of Bone.
    Xu W; Cai J; Meng T; Pang Y; Chen H
    Clin Nucl Med; 2023 May; 48(5):460-462. PubMed ID: 36800246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 68 Ga-FAPI-04 PET/CT in Selected Breast Cancer Patients With Low FDG Affinity : A Head-to-Head Comparative Study.
    Alçın G; Arslan E; Aksoy T; Cin M; Erol Fenercioğlu Ö; Beyhan E; Ergül N; Çermik TF
    Clin Nucl Med; 2023 Sep; 48(9):e420-e430. PubMed ID: 37351868
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [
    Lin R; Lin Z; Chen Z; Zheng S; Zhang J; Zang J; Miao W
    Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2960-2971. PubMed ID: 35462566
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    Zhao L; Chen S; Chen S; Pang Y; Dai Y; Hu S; Lin L; Fu L; Sun L; Wu H; Chen H; Lin Q
    Radiother Oncol; 2021 May; 158():55-61. PubMed ID: 33621587
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Utility of [
    Miao Y; Feng R; Guo R; Huang X; Hai W; Li J; Yu T; Qu Q; Zhang M; Shangguan C; Mi J; Zhu Z; Li B
    Eur Radiol; 2023 Jun; 33(6):4355-4366. PubMed ID: 36522509
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biodistribution, pharmacokinetics, dosimetry of [
    Ballal S; Yadav MP; Moon ES; Kramer VS; Roesch F; Kumari S; Tripathi M; ArunRaj ST; Sarswat S; Bal C
    Eur J Nucl Med Mol Imaging; 2021 Jun; 48(6):1915-1931. PubMed ID: 33244617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fibroblast Activation Protein and Glycolysis in Lymphoma Diagnosis: Comparison of
    Chen X; Wang S; Lai Y; Wang G; Wei M; Jin X; Ding J; Zhang Y; Shi Y; Wang F; Zhu H; Yang Z; Wang X
    J Nucl Med; 2023 Sep; 64(9):1399-1405. PubMed ID: 37385675
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of 68 Ga-FAPI and 18 F-FDG PET/CT in Finger Hidradenocarcinoma.
    Wang J; Wu J; Guan Y; Xu J; Xie F
    Clin Nucl Med; 2023 Mar; 48(3):e124-e125. PubMed ID: 36127792
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevated 18 F-AIF-FAPI-04 Uptake in Hepatic Hemangioma.
    Sun Y; Cai X; Wang Z; Sun Y; Cheng J
    Clin Nucl Med; 2024 Jan; 49(1):e25-e27. PubMed ID: 38015630
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of FAPI PET imaging in gastric cancer: a systematic review and meta-analysis.
    Ruan D; Zhao L; Cai J; Xu W; Sun L; Li J; Zhang J; Chen X; Chen H
    Theranostics; 2023; 13(13):4694-4710. PubMed ID: 37649615
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.